Skip to content

Corona Research Limburg

Corona Research Limburg - COL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49431
Enrollment
10000
Registered
2020-10-05
Start date
2020-10-23
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona antibodies SARS-CoV-2 antibodies

Interventions

None listed

Sponsors

GGD Zuid Limburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older and capable to read the study information and fill in the questionnaire; and willing to have their blood drawn for testing

Exclusion criteria

Exclusion criteria: younger than 18 years of age insufficienly capable to understand the Dutch language unwilling to have blood drawn for antibody testing

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of the study is the result of SARS-CoV-2 antibody testing (positive or negative), based on total IgG (dichotomous value).

Secondary

MeasureTime frame
The IgG titre (continuous value).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)